top of page

業績（2024年）

Publications

  1. Sasaki Y, Murai S, Shiozawa E, Yamochi T, Hattori N. Blastic Plasmacytoid Dendritic Cell Neoplasm in Long-Term Complete Remission After Venetoclax Monotherapy. Cureus. 2024 Jan 17;16(1):e52446. doi: 10.7759/cureus.52446. PMID: 38371152

  2. Shimada S, Kuroiwa K, Narita H, Okamura R, Uesugi Y, Sasaki Y, Watanuki M, Arai N, Kawaguchi Y, Fujiwara S, Yanagisawa K, Hattori N. Acquired thrombotic thrombocytopenic purpura during durvalumab monotherapy for non-small cell lung cancer. Rinsho Ketsueki. 2024;65(1):24-29. Japanese. doi: 10.11406/rinketsu.65.24. PMID: 38311385

  3. Miyazaki T, Tachibana T, Suzuki T, Izumi A, Fujimaki K, Sato S, Tamai Y, Michishita Y, Suzuki T, Ishii R, Hirasawa A, Hashimoto C, Kabasawa N, Inoue Y, Ishiyama T, Yamamoto K, Kanamori H, Tanaka M, Nakajima H. Pretransplantation Inflammatory and Nutritional Status in Elderly Allogeneic Hematopoietic Stem Cell Transplantation: Prognostic Value of C-Reactive Protein-to-Albumin Ratio. Transplant Cell Ther. 2024 Apr;30(4):400.e1-400.e9. doi: 10.1016/j.jtct.2024.01.068. PMID: 38253183

  4. Uesugi Y, Ikeda D, Fukumoto A, Tabata R, Miura D, Narita K, Takeuchi M, Matsue K. Use of the Second Revision of the International Staging System for prognostic stratification of multiple myeloma patients in real-world clinical practice and the importance of sub-groups, including age. Haematologica. 2024 May 1;109(5):1593-1597. doi: 10.3324/haematol.2023.284173. PMID: 38031801

  5. Arai S, Tachibana T, Izumi A, Takeda T, Tamai Y, Sato S, Hashimoto C, Fujimaki K, Ishii R, Kabasawa N, Hirasawa A, Inoue Y, Tanaka M, Suzuki T, Nakajima H. WT1-guided pre-emptive therapy after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia. Int J Hematol.  2024 Sep;120(3):337-346. doi: 10.1007/s12185-024-03795-z. PMID: 38795248

  6. Kuroiwa K, Sato M, Narita H, Okamura R, Uesugi Y, Sasaki Y, Shimada S, Watanuki M, Fujiwara S, Kawaguchi Y, Arai N, Yanagisawa K, Iezumi K, Hattori N. Influence of FOXP3 single-nucleotide polymorphism after allogeneic hematopoietic stem cell transplantation. Int J Hematol. 2024 May;119(5):583-591. doi: 10.1007/s12185-024-03726-y. PMID: 38418747

  7. Ido K, Nakamae H, Hattori N, Kanaya M, Morita K, Hino M, Ohigashi H, Fukuda T, Eto T, Nagafuji K, Hiramoto N, Maruyama Y, Ota S, Matsuoka KI, Ando T, Akasaka T, Mori Y, Kamimura T, Kawakita T, Kawamura K, Kanda J, Onizuka M, Atsuta Y, Murata M. Effect of peptide-binding motif on survival of HLA-haploidentical transplantation with post-transplant cyclophosphamide. Br J Haematol. 2024 Jul 7. doi: 10.1111/bjh.19630. PMID: 38972374

  8. Yoshizaki C, Yoshida Y, Nohmi S, Go Y, Kusakado R, Kawamura S, Inoue D, Kabasawa N, Yamaguchi F. EGFR-TKI-induced Factor V deficiency in a patient with advanced non-small cell lung cancer: The first case report. Lung Cancer. 2024 Aug:194:107869. doi: 10.1016/j.lungcan.2024.107869. PMID: 38970909

  9. Shima M, Suzuki N, Nishikii H, Amano K, Ogawa Y, Kobayashi R, Ozaki R, Yoneyama K, Mizuno N, Sakaida E, Saito M, Okamura T, Ito T, Hattori N, Higasa S, Seki Y, Nogami K. Final Analysis Results from the AGEHA Study: Emicizumab Prophylaxis for Acquired Hemophilia A with or without Immunosuppressive Therapy. Thromb Haemost. 2024 Aug 12. doi: 10.1055/a-2384-3585. PMID: 39134043

  10. Sasaki Y, Murai S, Hayashi H, Kawamata N, Nagao K, Kuroiwa K, Narita H, Okamura R, Shimada S, Watanuki M, Arai N, Kawaguchi Y, Yanagisawa K, Shiozawa E, Yamochi T, Hattori N. Clinicopathological differences in MYC and BCL2 protein expression between primary extranodal and nodal diffuse large B-cell lymphoma. Pathol Res Pract. 2024 Aug:260:155425. doi: 10.1016/j.prp.2024.155425. PMID: 38964118

  11. Suzuki S, Komiya K, Tsuda S, Yoshino M, Kaisho T, Bergsagel PL, Kawamura K, Fukuda T, Tokoyoda K.Type I-conventional dendritic cells support the progression of multiple myeloma in the bone marrow. Front Immunol. 2024 Oct 15;15:1444821. doi: 10.3389/fimmu.2024.1444821. PMID: 39474418

  12. Baba Y, Hida N, Sambe T, Abe M, Kabasawa N, Sakai H, Yoshimura K, Fukuda T.Efficacy of Venetoclax and Azacitidine in Acute Myeloid Leukemia Compared to Azacitidine Monotherapy: Real-World Experience.
    Anticancer Res. 2024 May;44(5):2003-2007. doi: 10.21873/anticanres.17003. PMID: 38677735

  13. Sasaki Y, Kawaguchi Y, Hayashi H, Kawamata N, Nagao K, Kuroiwa K, Narita H, Okamura R, Shimada S, Watanuki M, Arai N, Yanagisawa K, Hattori N. Disseminated toxoplasmosis confirmed by tachyzoites and cysts in bone marrow smear after cord blood transplantation. Rinsho Ketsueki. 2024;65(10):1253-1258. Japanese. doi: 10.11406/rinketsu.65.1253. PMID: 39505549

  14. Narita H, Kuroiwa K, Kawaguchi Y, Murai S, Sasaki Y, Homma M, Kawamata N, Hayashi H, Nagao K, Okamura R, Uesugi Y, Sasaki Y, Shimada S, Watanuki M, Arai N, Yanagisawa K, Shiozawa E, Yamochi T, Hattori N. High Ki-67 Expression Predicting a Risk Factor for the Progression of Disease within 24 Months and Microenvironment in Follicular Lymphoma. Int. J. Mol. Sci. 2024 Oct 15;25(20):11057.
    doi: 10.3390/ijms252011057. PMID: 39456838

  15. Arai N, Narita H, Kuroiwa K, Nagao K, Hayashi H, Kawamata N, Okamura R, Sasaki Y, Shimada S, Watanuki M, Kawaguchi Y, Yanagisawa K, Hattori N.　 Fludarabine Melphalan, Reduced-dose Busulfan Versus Fludarabine, Melphalan, Full-dose Busulfan in Patients Receiving Cord Blood Transplantation. Transplant Proc. 2024 Oct;56(8):1828-1835. doi: 10.1016/j.transproceed.2024.08.031. PMID: 39232926

bottom of page